Genetic polymorphisms and major bleeding risk during vitamin K antagonists treatment: The BLEEDS case-cohort.
- DOI
- 10.1002/phar.2923
- Published
- 2024-04-30
- Container
- Pharmacotherapy
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/phar.2923,
title = {Genetic polymorphisms and major bleeding risk during vitamin K antagonists treatment: The BLEEDS case-cohort.},
author = {Camilleri E and Ghobreyal M and Bos MHA and Reitsma PH and Van Der Meer FJM and Swen JJ and Cannegieter SC and van Rein N.},
year = {2024},
journal = {Pharmacotherapy},
doi = {10.1002/phar.2923},
url = {https://doi.org/10.1002/phar.2923}
}RIS
TY - JOUR TI - Genetic polymorphisms and major bleeding risk during vitamin K antagonists treatment: The BLEEDS case-cohort. AU - Camilleri E AU - Ghobreyal M AU - Bos MHA AU - Reitsma PH AU - Van Der Meer FJM AU - Swen JJ AU - Cannegieter SC AU - van Rein N. PY - 2024 JO - Pharmacotherapy DO - 10.1002/phar.2923 UR - https://doi.org/10.1002/phar.2923 ER -
APA
E, C., M, G., MHA, B., PH, R., FJM, V. D. M., JJ, S., SC, C., & N., V. R. (2024). Genetic polymorphisms and major bleeding risk during vitamin K antagonists treatment: The BLEEDS case-cohort.. Pharmacotherapy. https://doi.org/10.1002/phar.2923
Source records
- europe-pmc · retrieved 2026-09-26T19:24:08.106Z